Dustin Peterson, DPM
Podiatrist · Huntington, WVNPI 1972009439
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.1%), education and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 37.1% of the total. Reporting peaked in 2022 at $1,754 and has fallen 70.6% since, to $516 in 2025.
Across 83 payments — averaging $40.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$1K
- Darco International, Inc.$313
- AstraZeneca$308
- Treace Medical Concepts, Inc.$247
- Stryker$228
- Paratek Pharmaceuticals, Inc.$130
- plus $894 from 21 others
What the payments were for
- Consulting fees$3139%
- Food & beverage$1,85555%
- Education$1,20036%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 4 | $1,248 |
| Darco International, Inc. | 1 | $313 |
| AstraZeneca(2 entities) | 21 | $308 |
| Treace Medical Concepts, Inc. | 5 | $247 |
| Stryker | 3 | $228 |
| Paratek Pharmaceuticals, Inc. | 7 | $130 |
| Smith+Nephew | 1 | $114 |
| Bayer | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
| Shield Therapeutics Inc | 4 | $75 |
| Novo Nordisk | 4 | $64 |
| Organogenesis Inc. | 1 | $48 |
| AbbVie | 2 | $43 |
| Tactile Systems Technology Inc | 1 | $42 |
| Vifor Pharma, Inc. | 3 | $40 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Abbott | 1 | $30 |
| Mylan Specialty L.p. | 1 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Vertex | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Organon | 1 | $16 |
| Amgen | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,368 in reported general payments places this provider in the 75th percentile of 37 podiatrist providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $950 |
| Gabapentin | 37 | $799 |
| Pregabalin | 12 | $468 |
| Cephalexin | 24 | $314 |
| Ciprofloxacin Hcl | 30 | $241 |
| Terbinafine Hcl | 20 | $197 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $192 |
| Clotrimazole | 33 | $156 |
| Methylprednisolone | 22 | $138 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Huntington
- Kirt MillerHuntington$6K
- James ThomasHuntington$1K
- Kenneth AveryHuntington$789
- Douglas DockeryPrinceton$11K
- Marian KavanaughWheeling$6K
- Marshal GwynnPrinceton$5K
- Joseph GoodwinWheeling$5K
- Jerry HadrychFairmont$5K
- Jessica MullinsCharleston$5K
- Vincent OliverioPetersburg$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.